Search

Susanna Moore

Examiner (ID: 4754)

Most Active Art Unit
1624
Art Unit(s)
1624
Total Applications
1838
Issued Applications
1086
Pending Applications
196
Abandoned Applications
608

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16925233 [patent_doc_number] => 11046694 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-06-29 [patent_title] => Compounds and methods for treating bacterial infections [patent_app_type] => utility [patent_app_number] => 16/611065 [patent_app_country] => US [patent_app_date] => 2018-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 26736 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16611065 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/611065
Compounds and methods for treating bacterial infections May 7, 2018 Issued
Array ( [id] => 16720060 [patent_doc_number] => 20210087207 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-25 [patent_title] => PROCESS FOR PREPARING CHIRAL 2,3-DIHYDROTHIAZOLO[3,2-A]PYRIMIDIN-4-IUM COMPOUNDS [patent_app_type] => utility [patent_app_number] => 16/610186 [patent_app_country] => US [patent_app_date] => 2018-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11736 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16610186 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/610186
Process for preparing chiral 2,3-dihydrothiazolo[3,2-A] pyrimidin-4-ium compounds May 1, 2018 Issued
Array ( [id] => 15898399 [patent_doc_number] => 20200148718 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-14 [patent_title] => PHARMACEUTICAL-GRADE 20-HYDROXYECDYSONE EXTRACT, USE OF SAME AND PREPARATION THEREOF [patent_app_type] => utility [patent_app_number] => 16/609208 [patent_app_country] => US [patent_app_date] => 2018-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4166 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16609208 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/609208
PHARMACEUTICAL-GRADE 20-HYDROXYECDYSONE EXTRACT, USE OF SAME AND PREPARATION THEREOF Apr 29, 2018 Abandoned
Array ( [id] => 14791427 [patent_doc_number] => 10398699 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-09-03 [patent_title] => Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors [patent_app_type] => utility [patent_app_number] => 15/960069 [patent_app_country] => US [patent_app_date] => 2018-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 73029 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15960069 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/960069
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors Apr 22, 2018 Issued
Array ( [id] => 16222646 [patent_doc_number] => 20200247762 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-06 [patent_title] => K-RAS MODULATORS [patent_app_type] => utility [patent_app_number] => 16/605643 [patent_app_country] => US [patent_app_date] => 2018-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 70308 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16605643 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/605643
K-Ras modulators Apr 19, 2018 Issued
Array ( [id] => 13443995 [patent_doc_number] => 20180273540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-09-27 [patent_title] => PYRAZOLO[1,5-A]PYRIMIDINE-5,7-DIAMINE COMPOUNDS AS CDK INHIBITORS AND THEIR THERAPEUTIC USE [patent_app_type] => utility [patent_app_number] => 15/941063 [patent_app_country] => US [patent_app_date] => 2018-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34389 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15941063 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/941063
Pyrazolo[1,5-A]pyrimidine-5,7-diamine compounds as CDK inhibitors and their therapeutic use Mar 29, 2018 Issued
Array ( [id] => 16459464 [patent_doc_number] => 10842792 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-11-24 [patent_title] => Deuterated baricitinib [patent_app_type] => utility [patent_app_number] => 15/940964 [patent_app_country] => US [patent_app_date] => 2018-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7292 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15940964 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/940964
Deuterated baricitinib Mar 29, 2018 Issued
Array ( [id] => 13440589 [patent_doc_number] => 20180271837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-09-27 [patent_title] => ISOXAZOLE CARBOXAMIDE COMPOUNDS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 15/934176 [patent_app_country] => US [patent_app_date] => 2018-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26678 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 230 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15934176 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/934176
ISOXAZOLE CARBOXAMIDE COMPOUNDS AND USES THEREOF Mar 22, 2018 Abandoned
Array ( [id] => 14913537 [patent_doc_number] => 10428074 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-10-01 [patent_title] => Pyrrole heteroaryl ring derivative and method of use thereof [patent_app_type] => utility [patent_app_number] => 15/933371 [patent_app_country] => US [patent_app_date] => 2018-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31924 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15933371 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/933371
Pyrrole heteroaryl ring derivative and method of use thereof Mar 21, 2018 Issued
Array ( [id] => 16876826 [patent_doc_number] => 11026946 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-06-08 [patent_title] => Pharmacologically active alicyclic-substituted pyrazolo[1,5-a]pyrimidine derivatives [patent_app_type] => utility [patent_app_number] => 16/493453 [patent_app_country] => US [patent_app_date] => 2018-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9657 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16493453 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/493453
Pharmacologically active alicyclic-substituted pyrazolo[1,5-a]pyrimidine derivatives Mar 11, 2018 Issued
Array ( [id] => 15831719 [patent_doc_number] => 20200131141 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-30 [patent_title] => CHEMICAL COMPOUNDS [patent_app_type] => utility [patent_app_number] => 16/493816 [patent_app_country] => US [patent_app_date] => 2018-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24495 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16493816 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/493816
Urea derivatives and methods of use thereof Mar 11, 2018 Issued
Array ( [id] => 12884881 [patent_doc_number] => 20180186802 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-05 [patent_title] => COMPOUNDS AND COMPOSITIONS AS TOLL-LIKE RECEPTOR 7 AGONISTS [patent_app_type] => utility [patent_app_number] => 15/906424 [patent_app_country] => US [patent_app_date] => 2018-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22926 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 271 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15906424 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/906424
Compounds and compositions as toll-like receptor 7 agonists Feb 26, 2018 Issued
Array ( [id] => 12862126 [patent_doc_number] => 20180179216 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-06-28 [patent_title] => SUBSTITUTED [1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL COMPOUNDS AS PDE2 INHIBITORS [patent_app_type] => utility [patent_app_number] => 15/905672 [patent_app_country] => US [patent_app_date] => 2018-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38544 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15905672 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/905672
Substituted [1,2,4]triazolo[1,5-A]pyrimidin-7-yl compounds as PDE2 inhibitors Feb 25, 2018 Issued
Array ( [id] => 16558447 [patent_doc_number] => 20210003596 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-07 [patent_title] => CHEMILUMINESCENT ANDROSTENEDIONE CONJUGATES [patent_app_type] => utility [patent_app_number] => 16/488524 [patent_app_country] => US [patent_app_date] => 2018-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13015 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16488524 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/488524
CHEMILUMINESCENT ANDROSTENEDIONE CONJUGATES Feb 22, 2018 Pending
Array ( [id] => 16558447 [patent_doc_number] => 20210003596 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-07 [patent_title] => CHEMILUMINESCENT ANDROSTENEDIONE CONJUGATES [patent_app_type] => utility [patent_app_number] => 16/488524 [patent_app_country] => US [patent_app_date] => 2018-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13015 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16488524 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/488524
CHEMILUMINESCENT ANDROSTENEDIONE CONJUGATES Feb 22, 2018 Pending
Array ( [id] => 16206484 [patent_doc_number] => 20200239474 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-30 [patent_title] => PYRROLO-PYRIMIDINE DERIVATIVE COMPOUND, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME COMPOUND AS EFFECTIVE INGREDIENT FOR PREVENTING OR TREATING PROTEIN KINASE-RELATED DISEASE [patent_app_type] => utility [patent_app_number] => 16/488194 [patent_app_country] => US [patent_app_date] => 2018-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21648 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 439 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16488194 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/488194
Pyrrolo-pyrimidine derivative compound, preparation method therefor, and pharmaceutical composition comprising same compound as effective ingredient for preventing or treating protein kinase-related disease Feb 21, 2018 Issued
Array ( [id] => 13357191 [patent_doc_number] => 20180230135 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-16 [patent_title] => 3-INDOLYL FURANOIDS AS INHIBITORS OF MATRIX METALLOPROTEINASE-9 FOR PREVENTION OF GASTRIC ULCER AND OTHER INFLAMMATORY DISEASES [patent_app_type] => utility [patent_app_number] => 15/897688 [patent_app_country] => US [patent_app_date] => 2018-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7060 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15897688 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/897688
3-indolyl furanoids as inhibitors of matrix metalloproteinase-9 for prevention of gastric ulcer and other inflammatory diseases Feb 14, 2018 Issued
Array ( [id] => 12813082 [patent_doc_number] => 20180162864 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-06-14 [patent_title] => PYRROLOPYRIMIDINE COMPOUND OR SALT THEREOF AND COMPOSITIONS CONTAINING THE PYRROLOPYRIMIDINE COMPOUND OR SALT THEREOF [patent_app_type] => utility [patent_app_number] => 15/890470 [patent_app_country] => US [patent_app_date] => 2018-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42134 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 377 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15890470 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/890470
Pyrrolopyrimidine compound or salt thereof and compositions containing the pyrrolopyrimidine compound or salt thereof Feb 6, 2018 Issued
Array ( [id] => 12790546 [patent_doc_number] => 20180155351 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-06-07 [patent_title] => PYRROLOPYRIMIDINE COMPOUNDS AND THEIR USES [patent_app_type] => utility [patent_app_number] => 15/886014 [patent_app_country] => US [patent_app_date] => 2018-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26318 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15886014 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/886014
PYRROLOPYRIMIDINE COMPOUNDS AND THEIR USES Jan 31, 2018 Abandoned
Array ( [id] => 15178053 [patent_doc_number] => 20190359618 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-11-28 [patent_title] => COMPOUNDS FOR INHIBITING LRRK2 KINASE ACTIVITY [patent_app_type] => utility [patent_app_number] => 16/480762 [patent_app_country] => US [patent_app_date] => 2018-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29721 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16480762 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/480762
Compounds for inhibiting LRRK2 kinase activity Jan 22, 2018 Issued
Menu